ImmunoPrecise Antibodies Ltd (IPA)
0.4001
-0.02
(-4.76%)
USD |
NASDAQ |
Dec 20, 16:00
0.4014
0.00 (0.00%)
After-Hours: 20:00
ImmunoPrecise Antibodies Total Assets (Quarterly): 43.11M for Oct. 31, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 3.814M |
| Lexaria Bioscience Corp | 8.868M |
| Xenon Pharmaceuticals Inc | 835.90M |
| ESSA Pharma Inc | 128.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.62M |
| Shareholders Equity (Quarterly) | 23.49M |
| Debt to Equity Ratio | 0.0947 |
| Current Ratio | 1.008 |
| Net Debt Paydown Yield | -3.08% |